Aquestive Under Pressure After Generic Suboxone Patent Decision
November 21, 2018 at 15:48 PM EST
In afternoon trading, shares of Aquestive have dropped over 23% to $10.11
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|